DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: API

Topstories

Understanding the Requirements of Safe HPAPI Manufacturing

11.09.2020 -

The pharmaceutical industry is increasingly focused on the development of specialized drug products with new treatment modalities, including previously undruggable...

Topstories

The Impact of Covid-19 on the Pharmaceutical Industry

31.08.2020 -

Andrew Badrot, CEO of C2 Pharma and a close observer of pharma industry trends, analyzes the current situation and how this pandemic may kick of changes in the pharma...

Topstories

The Risk of Dependency in Pharma Supply Chains

29.05.2020 - In recent decades, outsourcing of production steps, especially to Asia, has been one of the most important trends in manufacturing strategies in both the European and the US...

Topstories

Biomade Peptides

09.09.2019 - Peptides make up around 8% of all active pharmaceutical ingredients (APIs). Those molecules are short polymers formed from the linking of ≤100 amino acids. They comprise some of...

News

Cerbios Expands HPAI Manufacturing Capacity

24.01.2019 - Lugano, Switzerland-based chemical and biological API manufacturer Cerbios announced that its board of directors has approved the installation of a new production line in its...

News

Mallinckrodt to Split Into two Parts

12.12.2018 - Mallinckrodt Pharmaceuticals, the UK-domiciled, US-focused specialty drugmaker, plans to break up into two differentiated companies, with one focused on innovative specialty...

Topstories

Industry 4.0 Will Be a Game Changer for the Chemical Business

05.10.2018 - Global competition is pushing the industry towards faster time-to-market and more efficient and flexible processes. Modular plants are considered as potential bridges between the...

News

Lonza and Clovis Open New Monoplant for Ovarian Cancer Drug

04.10.2018 - Lonza and Clovis Oncology have opened a new, dedicated production train for Rubraca (rucaparib), at Lonza’s Visp site in Switzerland. Rubraca is Clovis’ US- and EU-approved drug...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.